Herbal granule add-on therapy for h. pylori and fatty liver disease
Part of Digestive system, Infections clinical trials.
This trial tests adding a herbal granule (Huazhi Rougan) to the standard treatment for H. pylori infection in people who also have metabolic-associated steatohepatitis (MASH, a fatty liver disease with inflammation). The goal is to see if the combination can help treat both the infection and maybe improve liver health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have a positive test for H. pylori (a bacteria in your stomach) and have not been treated for it yet.
- You have been diagnosed with metabolic-associated steatohepatitis (MASH, a type of fatty liver with liver inflammation).
- You are not pregnant or breastfeeding.
- You do not have severe liver cirrhosis (like fluid in the belly or very low sodium), active hepatitis from viruses, or a history of cancer.
- You have not taken certain liver-protecting or cholesterol-lowering medicines that could interfere with the study, and you have not used Chinese herbs for fatty liver in the past 2 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two different antibiotic combinations to treat H. pylori, a common stomach bacteria that causes indigestion and ulcers. One uses a newer acid-blocking medicine (vonoprazan) and the other uses a standard one (esomeprazole), both paired with antibiotics.
This study tests a new antibiotic combination to treat stomach infections caused by H. pylori bacteria. It may help clear the infection and reduce stomach problems.
This trial tests a new two-step antibiotic treatment for adults with chronic gastritis caused by H. pylori bacteria. If you have not been treated for H. pylori before and are between 18 and 70, you may be able to join.
This trial compares a newer drug (vonoprazan) plus antibiotics to the standard triple therapy for eradicating H. pylori infection in the stomach. It may be a good option if you have stomach symptoms like indigestion, acid reflux, or a non-bleeding ulcer and have not been treated for H. pylori before.
This study tests a new medicine called Keverprazan, which may help get rid of the H. pylori bacteria that causes stomach ulcers and other problems. If you have H. pylori and haven't been treated before, this trial could help you clear the infection with a new approach.
This trial tests whether treating H. pylori infection can help improve metabolic syndrome (a group of conditions like high blood sugar, abnormal cholesterol, and high blood pressure). It aims to understand how treatment changes your gut bacteria and overall health.
Hear when a new Helicobacter Pylori Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.